Glen Harbor Capital Management’s Magellan Health Services, Inc. MGLN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$349K Buy
5,610
+680
+14% +$45.3K 0.01% 830
2019
Q2
$366K Hold
4,930
0.01% 817
2019
Q1
$325K Hold
4,930
0.01% 842
2018
Q4
$280K Hold
4,930
0.01% 840
2018
Q3
$355K Buy
4,930
+782
+19% +$62.9K 0.01% 859
2018
Q2
$398K Hold
4,148
0.01% 721
2018
Q1
$444K Hold
4,148
0.01% 681
2017
Q4
$400K Buy
4,148
+714
+21% +$63.2K 0.01% 723
2017
Q3
$296K Buy
3,434
+442
+15% +$34.8K 0.01% 778
2017
Q2
$218K Buy
2,992
+1,292
+76% +$90.8K 0.01% 837
2017
Q1
$117K Sell
1,700
-578
-25% -$42.2K ﹤0.01% 892
2016
Q4
$171K Buy
+2,278
New +$146K ﹤0.01% 735

Other funds holding MGLN

Glen Harbor Capital Management's MGLN Position: Q3 2019 in Review

Glen Harbor Capital Management increased its Magellan Health Services, Inc. (MGLN) stake by 14% in Q3 2019, buying an estimated $45.3K and bringing the position to 5,610 shares worth $349K. The position accounts for 0.01% of the portfolio, ranked #830.

Glen Harbor Capital Management first reported a position in MGLN in Q4 2016 and has held it in 12 quarters since. The position peaked at $444K in Q1 2018. 209 funds tracked by Wall St. Rank hold MGLN as of Q3 2019.

  • Glen Harbor Capital Management held 5,610 shares of Magellan Health Services, Inc. worth $349K as of Q3 2019.
  • Glen Harbor Capital Management bought 680 Magellan Health Services, Inc. shares in Q3 2019, an estimated $45.3K.
  • Magellan Health Services, Inc. made up 0.01% of Glen Harbor Capital Management's portfolio in Q3 2019, its #830 holding.
  • Glen Harbor Capital Management first reported a position in Magellan Health Services, Inc. in Q4 2016 and has held it in 12 quarters since.
  • Glen Harbor Capital Management's Magellan Health Services, Inc. position peaked at $444K in Q1 2018.
  • 209 funds tracked by Wall St. Rank held Magellan Health Services, Inc. as of Q3 2019.

Based on Glen Harbor Capital Management's 13F filing for Q3 2019, filed 13 Nov 2019.